Ever since its inception, acrodermatitis continua of Hallopeau, has been recognized as an uncommon clinical entity which has been sparingly reported from across the globe. The attempt to have cumulative information on prevalent nomenclature, definition, reminiscences, and clinical overtures has brought differential diagnosis and diagnosis in sharp focus, the highlights of which are outlined. Hence, it was considered important to review the evolution of treatment options available thus far including use of biologics.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-4632.2011.04993.xDOI Listing

Publication Analysis

Top Keywords

acrodermatitis continua
8
continua hallopeau
8
evolution treatment
8
treatment options
8
hallopeau evolution
4
options inception
4
inception acrodermatitis
4
hallopeau recognized
4
recognized uncommon
4
uncommon clinical
4

Similar Publications

Background: Acrodermatitis continua of Hallopeau (ACH) is a rare pustular psoriasis variant predominantly affects the distal phalanges of the fingers and toes. However, data on aggravating factors and treatment outcomes is limited.

Objective: This study aims to analyze the aggravating factors and treatment outcomes of ACH in a three-tertiary-hospital in South China.

View Article and Find Full Text PDF

Is tofacitinib monotherapy also effective for the treatment of Acrodermatitis continua of Hallopeau?

Australas J Dermatol

December 2024

Zhejiang Provincial Key Laboratory of Traditional Chinese Medicine Cultivation for Arthritis Diagnosis and Treatment, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!